UT Southwestern Radiation Oncology provides state-of-the-art treatment for all stages of breast cancer, including post-mastectomy irradiation, breast conservation treatment with whole breast irradiation, and accelerated partial breast irradiation.
Disease-specific indications considered for treatment include intraductal carcinoma (also known as ductal carcinoma in situ, DCIS), lobular carcinoma in situ (LCIS), infiltrating (or invasive) ductal carcinoma, infiltrating (or invasive) lobular carcinoma, medullary carcinoma, and sarcomas of the breast and chest wall.
For patients undergoing post-operative or whole breast treatment, intensity-modulated radiation therapy (IMRT) may be used to optimize coverage of the breast while decreasing the radiation delivered to the adjacent normal structures (including the heart and opposite breast). Among our newer technologies is an advanced 3-D video surveillance system (AlignRT) for optimizing radiation dose delivery to breast cancer patients in combination with the deep inspiration breath-hold technique.
For accelerated partial breast irradiation, UT Southwestern is one of the few sites in the U.S. offering treatment on the CyberKnife for carefully selected patients with early stage disease.
UT Southwestern Radiation Oncology is affiliated with Harold C. Simmons Comprehensive Cancer Center and interacts in multi-disciplinary consultation and management with medical oncologists and surgeons. We actively participate in clinical research when appropriate and offer patients the option of participating in trials offered by national collaborative groups (NSABP, RTOG, and CALGB), as well as investigator-initiated and industry-sponsored clinical trials.